[Pharmacological properties of new antidepressive agent azaphen].
D000109:Acetylcholine / Q000037:antagonists & inhibitors; D000661:Amphetamine / Q000494:pharmacology* / Q000633:toxicity; D000818:Animals; D000928:Antidepressive Agents / Q000494:pharmacology* / Q000633:toxicity; D001158:Arteries; D001463:Barbiturates / Q000494:pharmacology; D001794:Blood Pressure / Q000187:drug effects*; D002415:Cats; D004357:Drug Synergism; D004837:Epinephrine / Q000494:pharmacology*; D005334:Fever / Q000139:chemically induced; D007036:Hypothermia, Induced; D007099:Imipramine / Q000494:pharmacology; D066298:In Vitro Techniques; D007422:Intestines / Q000187:drug effects; D051379:Mice; D009539:Nicotinic Acids; D009541:Nictitating Membrane / Q000187:drug effects; D009638:Norepinephrine / Q000494:pharmacology*; D010276:Parasympatholytics / Q000494:pharmacology; D010880:Piperidines / Q000494:pharmacology; D011817:Rabbits; D051381:Rats; D012110:Reserpine / Q000037:antagonists & inhibitors*; D012119:Respiration / Q000187:drug effects; D012890:Sleep / Q000187:drug effects*; D013035:Spasm / Q000139:chemically induced; D013268:Stimulation, Chemical; D013747:Tetrabenazine / Q000037:antagonists & inhibitors*; D014202:Tremor / Q000139:chemically induced; D014268:Trifluoperazine / Q000037:antagonists & inhibitors*; D014363:Tryptamines
D000928:Antidepressive Agents; D001463:Barbiturates; D009539:Nicotinic Acids; D010276:Parasympatholytics; D010880:Piperidines; D014363:Tryptamines; D014268:Trifluoperazine; D012110:Reserpine; D000661:Amphetamine; D000109:Acetylcholine; D007099:Imipramine; D009638:Norepinephrine; D004837:Epinephrine; D013747:Tetrabenazine
Farmakologicheskie svoĭstva novogo antidepressivnogo preparata azafena.